Suppr超能文献

基于 APP 的胰岛素计算器:现状和未来。

App-Based Insulin Calculators: Current and Future State.

机构信息

Division of Diabetes, Endocrinology & Metabolism, University of Nebraska Medical Center, Omaha, NE, USA.

Nebraska Medicine - Diabetes Center, University of Nebraska Medical Center, 984120 Nebraska Medical Center, Omaha, NE, 68198-4120, USA.

出版信息

Curr Diab Rep. 2018 Oct 4;18(11):123. doi: 10.1007/s11892-018-1097-y.

Abstract

PURPOSE OF REVIEW

To perform a comprehensive literature review and critical assessment of peer-reviewed manuscripts addressing the efficacy, safety, or usability of insulin calculator apps.

RECENT FINDINGS

Managing diabetes with insulin can be complex, and literacy and numeracy skills pose barriers to manual insulin dose calculations. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve glycemic control. While a large number of apps which assist with insulin dosing are available, there is limited data evaluating their efficacy, safety, and usability. Recently, a need for regulatory oversight has been recognized, but few apps meet federal standards. Thus, choosing an appropriate app is challenging for both patients and providers. An electronic literature review was performed to identify insulin calculator apps with either evidence for efficacy, safety or usability published in peer-reviewed literature or with FDA/CE approval. Twenty apps were identified intended for use by patients with diabetes on insulin. Of these, nine included insulin calculators. Summaries of each app, including pros and cons, are provided. Insulin-calculator apps have the potential to improve self-management of diabetes. While current literature demonstrates improvements in quality of life and glycemic control after use of these programs, larger trials are needed to collect outcome and safety data. Also, further human factor analysis is needed to assure these apps will be adopted appropriately by people with diabetes. App features including efficacy and safety data need to be easily available for consumer review and decision making. Higher standards need to be set for app developers to ensure safety and efficacy.

摘要

目的综述

对评估胰岛素计算器应用程序的疗效、安全性或可用性的同行评议文献进行全面综述和批判性评估。

最新发现

用胰岛素治疗糖尿病可能很复杂,而读写和计算能力则是手动胰岛素剂量计算的障碍。基于应用程序的胰岛素计算器是帮助糖尿病患者安全管理胰岛素的有前途的工具,并且有可能改善血糖控制。虽然有大量的应用程序可以帮助胰岛素给药,但评估其疗效、安全性和可用性的数据有限。最近,人们认识到需要监管监督,但很少有应用程序符合联邦标准。因此,对于患者和提供者来说,选择合适的应用程序具有挑战性。进行了电子文献综述,以确定在同行评议文献中发表的或经 FDA/CE 批准的具有疗效、安全性或可用性证据的胰岛素计算器应用程序。确定了 20 个旨在供糖尿病患者使用胰岛素的应用程序。其中,9 个应用程序包括胰岛素计算器。提供了每个应用程序的摘要,包括优缺点。胰岛素计算器应用程序有可能改善糖尿病的自我管理。虽然目前的文献表明,使用这些程序后生活质量和血糖控制得到了改善,但需要更大规模的试验来收集结果和安全性数据。还需要进行更多的人为因素分析,以确保这些应用程序将被糖尿病患者适当采用。应用程序功能,包括疗效和安全性数据,需要方便消费者查看和决策。需要为应用程序开发人员设定更高的标准,以确保安全性和疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验